Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lexaria announces voluntary delisting from CSE to concentrate trading on Nasdaq

Stockhouse Editorial
3 Comments| July 6, 2021

{{labelSign}}  Favorites
{{errorMessage}}

Canadian bioscience company Lexaria Bioscience Corp. (NASDAQ: LEXX, CSE: LXX, NASDAQ: LEXXW, Forum) has announced that commencing June 30, 2021 it has made a request to voluntarily delist its common shares from the Canadian Securities Exchange (CSE).

It is expected that the close of business on Wednesday, July 7, 2021 will be the final trading day for Lexaria on the CSE. At the open of the trading day on July 8, 2021, the Company's shares will only trade on the NASDAQ Capital Markets (Nasdaq).

Full story, click here.


New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.


FULL DISCLOSURE: Lexaria Bioscience Corp. is a client of Stockhouse Publishing.


{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today